Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Idiopathic Pulmonary Fibrosis | Treatment Algorithms: Claims Data Analysis | US | 2019
Idiopathic pulmonary fibrosis (IPF) is an orphan disease affecting approximately 50,000 people in the United States. It is characterized by an irreversible loss of lung function, leading to high…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Inducible Urticaria | US | 2019
Market Outlook Chronic inducible urticaria (CIndU) includes different chronic urticaria subtypes that are inducible by specific triggers. Evidence exists that CIndU appears to be more resistant…
Peripheral Arterial Disease | Treatment Algorithms: Claims Data Analysis | US | 2019
Peripheral arterial disease (PAD) is a complex manifestation of underlying atherosclerotic disease and is closely associated with coronary and cerebrovascular disease. Current treatment practice…
Scleroderma (Systemic Sclerosis) | Treatment Algorithms: Claims Data Analysis | US | 2019
Scleroderma (systemic sclerosis [SSc]) is a rare progressive autoimmune disorder characterized by skin fibrosis, systemic inflammation, and varying degrees of vasculopathy that manifest as Raynaud…
Crohn’s Disease | Treatment Algorithms: Claims Data Analysis | Adult | US | 2019
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS Without Diarrhea (Including IBS-Constipation) | US | 2019
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is generally classified into three…
